# A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Management Of Depression

> **NCT02189057** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 160 (actual)

## Conditions studied

- Depression
- Mood Disorder
- Bipolar

## Interventions

- **OTHER:** AssureRx GeneSight genotyping results
- **OTHER:** Treatment as usual

## Key facts

- **NCT ID:** NCT02189057
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2018-10-19
- **Final completion:** 2018-10-19
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2018-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02189057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02189057, "A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Management Of Depression". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02189057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*